Levofloxacin Structure (Levofloxacin Injection In 5 Percent Dextrose Nov 1)
Levofloxacin Injection, Solution
Product Images NDC 0143-9315
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 0143-9315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 750 mg (Levofloxacin Injection In 5 Percent Dextrose Nov 2)
This text describes a medication available in two forms: a tablet to be taken orally at a dose of 750mg, and an intravenous infusion with the same dose that will take 90 minutes to administer. The medication name or purpose is not provided.*
Figure 3: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 500 mg (Levofloxacin Injection In 5 Percent Dextrose Nov 3)
0143931501 (Levofloxacin Injection In 5 Percent Dextrose Nov 4)
This is a medication guide for Levofloxacin Injection. This medication is for intravenous infusion over 60 minutes and contains 250 mg of Levofloxacin in 5% dextrose. The package insert contains the recommended dosage for normal adults. Additives should not be added or infused through the same intravenous line. The overwrap should be left on until use, and the single-dose container should be checked for minute leaks by squeezing firmly after overwrap removal. The solution should be clear and undamaged, and the unused portion should be discarded immediately.*
0143931601 (Levofloxacin Injection In 5 Percent Dextrose Nov 5)
This is a medication guide for Levofoxacin Injection in 5% Dextrose used to treat bacterial infections through intravenous infusion. The bag should stay in its overwrap until use, and it must be infused over 60 minutes. The standard adult dosage should be followed as per the package insert. The bag should be discarded if leakage is found, and only clear and undamaged solutions should be used. The storage temperature should not exceed 25°C, and the solution should be protected from light, excessive heat, and freezing. The text also includes information about the manufacturer and trademarks.*
0143931701 (Levofloxacin Injection In 5 Percent Dextrose Nov 6)
This is a medication guide for Levofloxacin Injection, to be administered through intravenous infusion of 750mg in 150mL 5% Dextrose over 90 minutes. The bag containing the medication must be left in overwrap until use, and pharmacists should dispense a medication guide for each patient. The recommended storage is below 25°C (77°F), but brief exposure up to 40°C (104°F) is acceptable. The single-dose container should not have any additives or infused through the same intravenous line. Use unit promptly when the overwrap is open or discard the unused portion. The Lot and Bg are not available.*
Layout 1 (Levofloxacin Injection In 5 Percent Dextrose Nov 7)
This is a product identification code that includes the Global Trade Item Number (GTIN), serial number (SN), expiration date (EXP), and LOT number (LOT). However, the specific information regarding the product is not available.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
